232 related articles for article (PubMed ID: 35618884)
21. Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up.
Jeong HS; Lim HS; Park HJ; Lee WS; Choi JO; Lee HS; Jo SH; Hong SJ
Sci Rep; 2021 Jan; 11(1):1783. PubMed ID: 33469103
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of the combination of amlodipine and candesartan in hypertensive patients with coronary artery disease: a subanalysis of the HIJ-CREATE study.
Koyanagi R; Hagiwara N; Yamaguchi J; Kawada-Watanabe E; Haruta S; Takagi A; Ogawa H;
J Cardiol; 2013 Oct; 62(4):217-23. PubMed ID: 23778009
[TBL] [Abstract][Full Text] [Related]
23. Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy.
Jukema JW; van der Hoorn JW
Expert Opin Pharmacother; 2004 Feb; 5(2):459-68. PubMed ID: 14996641
[TBL] [Abstract][Full Text] [Related]
24. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.
Wright JT; Dunn JK; Cutler JA; Davis BR; Cushman WC; Ford CE; Haywood LJ; Leenen FH; Margolis KL; Papademetriou V; Probstfield JL; Whelton PK; Habib GB;
JAMA; 2005 Apr; 293(13):1595-608. PubMed ID: 15811979
[TBL] [Abstract][Full Text] [Related]
25. Comparison of calcium-channel blockers for long-term clinical outcomes in patients with vasospastic angina.
Kim SE; Jo SH; Han SH; Lee KY; Her SH; Lee MH; Seo WW; Cho SS; Baek SH
Korean J Intern Med; 2021 Jan; 36(1):124-134. PubMed ID: 32088938
[TBL] [Abstract][Full Text] [Related]
26. Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: A meta-analysis of prospective studies.
Hussain S; Singh A; Rahman SO; Habib A; Najmi AK
Neurosci Lett; 2018 Apr; 671():120-127. PubMed ID: 29452176
[TBL] [Abstract][Full Text] [Related]
27. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
Opie LH
Am J Hypertens; 1997 May; 10(5 Pt 1):565-77. PubMed ID: 9160770
[TBL] [Abstract][Full Text] [Related]
28. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
Bulpitt CJ; Palmer AJ; Beevers DG; Coles EC; Ledingham JG; Petrie JC; Webster J
J Hum Hypertens; 1997 Apr; 11(4):205-11. PubMed ID: 9185024
[TBL] [Abstract][Full Text] [Related]
29. Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study.
Bateman BT; Hernandez-Diaz S; Huybrechts KF; Palmsten K; Mogun H; Ecker JL; Seely EW; Fischer MA
BJOG; 2013 Dec; 120(13):1668-76; dicussion 1676-7. PubMed ID: 24020971
[TBL] [Abstract][Full Text] [Related]
30. Effects of combination therapy with angiotensin II type I receptor blockers and calcium channel blockers on renal function in hypertensive patients/a retrospective, "real-world" comparative study.
Yamada H; Suga N; Maeda K; Kimura Y; Miura N; Futenma A; Imai H
Arzneimittelforschung; 2010; 60(2):64-70. PubMed ID: 20329653
[TBL] [Abstract][Full Text] [Related]
31. The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
Harmsze AM; Robijns K; van Werkum JW; Breet NJ; Hackeng CM; Ten Berg JM; Ruven HJ; Klungel OH; de Boer A; Deneer VH
Thromb Haemost; 2010 May; 103(5):920-5. PubMed ID: 20352154
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension.
Savage RD; Visentin JD; Bronskill SE; Wang X; Gruneir A; Giannakeas V; Guan J; Lam K; Luke MJ; Read SH; Stall NM; Wu W; Zhu L; Rochon PA; McCarthy LM
JAMA Intern Med; 2020 May; 180(5):643-651. PubMed ID: 32091538
[TBL] [Abstract][Full Text] [Related]
33. Identifying the Transcriptome Signatures of Calcium Channel Blockers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Lam CK; Tian L; Belbachir N; Wnorowski A; Shrestha R; Ma N; Kitani T; Rhee JW; Wu JC
Circ Res; 2019 Jul; 125(2):212-222. PubMed ID: 31079550
[TBL] [Abstract][Full Text] [Related]
34. Age-related difference in the sleep pressure-lowering effect between an angiotensin II receptor blocker and a calcium channel blocker in Asian hypertensives: the ACS1 Study.
Kario K; Hoshide S
Hypertension; 2015 Apr; 65(4):729-35. PubMed ID: 25646296
[TBL] [Abstract][Full Text] [Related]
35. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
[TBL] [Abstract][Full Text] [Related]
36. Effects of benidipine, a long-acting T-type calcium channel blocker, on home blood pressure and renal function in patients with essential hypertension: a retrospective, 'real-world' comparison with amlodipine.
Ohta M; Sugawara S; Sato N; Kuriyama C; Hoshino C; Kikuchi A
Clin Drug Investig; 2009; 29(11):739-46. PubMed ID: 19813777
[TBL] [Abstract][Full Text] [Related]
37. Rate Control With Beta-blockers Versus Calcium Channel Blockers in the Emergency Setting: Predictors of Medication Class Choice and Associated Hospitalization.
Atzema CL; Austin PC
Acad Emerg Med; 2017 Nov; 24(11):1334-1348. PubMed ID: 28853232
[TBL] [Abstract][Full Text] [Related]
38. Calcium channel blockers as initial therapeutic agents in hypertension: relationship to incident heart failure.
Shields DL
Biol Res Nurs; 2014 Jul; 16(3):266-77. PubMed ID: 23864228
[TBL] [Abstract][Full Text] [Related]
39. Class differences in the effects of calcium channel blockers in the rat remnant kidney model.
Griffin KA; Picken MM; Bakris GL; Bidani AK
Kidney Int; 1999 May; 55(5):1849-60. PubMed ID: 10231447
[TBL] [Abstract][Full Text] [Related]
40. Voltage-gated calcium channel blockers for psychiatric disorders: genomic reappraisal.
Harrison PJ; Tunbridge EM; Dolphin AC; Hall J
Br J Psychiatry; 2020 May; 216(5):250-253. PubMed ID: 31230606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
